FMI analysis indicates that the photoaging treatment market will shift toward precision dermatology platforms that outperform generalized anti-aging products in managing complex sun-induced damage. This evolution will transform photoaging treatments from cosmetic consumables into clinically positioned, outcome-driven therapeutic assets.